Search for: "Astra Zeneca" Results 21 - 40 of 63
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Apr 2012, 2:30 am
With so many popular antidepressants' exclusivity patents getting ready to expire soon and more recent drugs to hit the market like Astra Zeneca failing, many drug manufacturers just lost interest in developing newer drugs. [read post]
13 Feb 2012, 8:44 am by Sara Randazzo
Sullivan--whose recent trial wins for Philip Morris and Astra-Zeneca helped earn her recognition as a finalist in The American Lawyer's Litigator of the Year competition last year--joins Weil, Gotshal & Manges in New York with fellow litigator Kathleen O'Connor. [read post]
2 Dec 2011, 5:36 am by Lawrence B. Ebert
However, Astra- Zeneca did not need to appreciate which component was responsible for the stabilization. [read post]
16 Sep 2011, 11:02 am by eithurburn@getnicklaw.com
  The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]
13 Jun 2011, 9:08 am
The three most commonly prescribed atypical antipsychotic drugs are listed in the article as Astra Zeneca's Seroquel, Johnson & Johnson's Risperdal, and Ely Lilly's Zyprexa. [read post]
2 Jun 2011, 12:46 pm by Bexis
It was the last blank space on the legal map – the only state with no precedent whatsoever. [read post]
25 May 2011, 5:47 am by LaBovick Law
The eight pharmaceutical manufacturers in the case included subsidiaries of Astra Zeneca, Sanofi-Aventis SA, Bayer AG, Takeda Pharmaceutical, Bristol Myers Squibb, Merck, Pfizer and GlaxoSmithKine. [read post]
12 Apr 2011, 12:00 am by JA Hodnicki
BOOK ABSTRACT: This book looks at how the leveraging strategies of Microsoft, the patent enhancement strategies of Astra Zeneca and Rambus... [read post]
12 Apr 2011, 12:00 am by JA Hodnicki
BOOK ABSTRACT: This book looks at how the leveraging strategies of Microsoft, the patent enhancement strategies of Astra Zeneca and Rambus... [read post]
31 Mar 2011, 7:46 am by admin
-based AstraZeneca plc announced that it will pay the Internal Revenue Service $1.1 billion to settle all transfer pricing issues for 2000-10, according to a March 28 statement released by the company.Astrazeneca also noted that the company settled with the IRS on the related valuation matter of a 2000 restructuring that followed the 1999 merger of Astra AB and Zeneca Group plc.In addition to the IRS settlement, the company said that the U.S. and U.K. [read post]
11 Mar 2011, 5:08 am by Mark Zamora
Image via WikipediaIn a lawsuit against the makers of Seroquel, Astra Zeneca - it was claimed that the company marketed Seroquel for uses that weren’t approved by the U.S. [read post]
10 Jan 2011, 6:35 am by Kiran Bhat
Robert Pear reports in the New York Times on the Obama administration’s unexpected support for drug maker Astra Zeneca in Astra USA, Inc. v. [read post]
9 Nov 2010, 10:52 am by Lawrence B. Ebert
On November 12, 2007, almost eight months after filing suit, AZ-UK, in a sepa- rate document entitled “Intellectual Property Assignment Agreement,” “confirm[ed] the sale, assignment, convey- ance and transfer to Abraxis, for Abraxis’ sole and exclu- sive use and enjoyment, of all of Astra Zeneca UK’s right, title, and interest, in and to” the asserted patents. [read post]
4 Nov 2010, 6:14 am by Lawrence B. Ebert
Both Astra- Zeneca and Apotex rely on the testimony of Richard Fante, the president of AstraZeneca. [read post]
11 May 2010, 1:10 pm by FDABlog HPM
  HCP reports have already spurred a number of letters; one of the more recent is an Untitled Letter to Astra Zeneca from December 2008 about misleading sales representative statements that solicited a request for more information about an off-label use for Seroquel. [read post]
28 Apr 2010, 10:40 am
Astra Zeneca, although continuing to deny that it did anything wrong, will nevertheless poney up over a half billion dollars. [read post]
28 Apr 2010, 7:14 am by Mark Zamora
AstraZeneca has finalized its agreement with US federal and state entities, under which it will pay $520 million to resolve allegations that it marketed the anti-psychotic drug Seroquel for off-label uses.The US contends that the company promoted the drug to doctors who do not typically treat schizophrenia or bipolar disorder, for which the drug is FDA approved. [read post]
19 Apr 2010, 11:39 am by Phillips & Cohen
It details the activities and successes of NY's MFCU.The report highlights Operation Home Alone, an investigation of corruption in the home care industry; settlements with several pharmaceutical companies, including Eli Lilly, Pfizer, Mylan Pharmaceuticals, Astra Zeneca, and Aventis for off-label marketing, kickbacks, misreporting prices, and other fraud; nursing home fraud investigations; and other types of program fraud. [read post]